Latest Breaking News On - Lindaa johnson - Page 1 : comparemela.com

This July 2021 image provided by Viatris shows Semglee insulin. On Wednesday, July 28, 2021, U.S. regulators took action that will make it easier to get a cheaper and similar version of a brand-name insulin at the drugstore. The Food and Drug Administration agreed that Viatris Inc.’s Semglee was interchangeable with widely use Lantus, a fast-acting insulin. (Viatris via AP) FDA allows automatic generic swap for brand-name insulin By Associated Press Lexington SHARE U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of a brand-name insulin at the drugstore. Doctors now have to specifically prescribe what’s called a biosimilar or OK substituting it for a more expensive brand-name insulin.

Lindaa johnsonSean mcgowanScience departmentDrug administrationAssociated pressViatris incAssociated press healthHoward hughes medical instituteசீன் மகோவெந்அறிவியல் துறைதொடர்புடையது ப்ரெஸ்தொடர்புடையது ப்ரெஸ் ஆரோக்கியம்ஹோவர்ட் ஹக்ஸ் மருத்துவ நிறுவனம்